VNP40101M in Treating Patients With Advanced or Metastatic Cancer

NCT00049699 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Lymphoma
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: laromustine

Sponsor

Vion Pharmaceuticals